Vanqua Bio logo

Vanqua Bio jobs and careers

Chicago, IL, United States

About Vanqua Bio

Vanqua Bio is helping usher in a new era of hope for the millions of people living with neurodegenerative diseases. Our unique drug-development approach is designed to overcome longstanding challenges in the neuroscience field by capitalizing on the power of human genetics to identify genes that cause or increase the risk of neurodegenerative disease. We leverage novel, proprietary research tools and in vitro modeling of disease, based on patient-derived neuronal cells, to develop transformative therapies that slow or stop the progression of Parkinson’s disease (PD), Alzheimer’s disease (AD), amyotrophic lateral sclerosis (ALS) and Gaucher disease (GD).

Founded in 2019 by James Sullivan.

Founded
2019
Employees
11 to 50
Total funding
$130M
Headquarters
Chicago

Leadership

The top of Vanqua Bio's org chart, with how many people report into each leader.

JSPhoto of Jim Sullivan

Jim Sullivan

CEO

10 reports

JBPhoto of Jack Beyer

Jack Beyer

Chief Business Officer

3 reports

KHPhoto of Kevin Hunt

Kevin Hunt

Chief Scientific Officer

3 reports

MFPhoto of Maurizio Facheris

Maurizio Facheris

CMO

JCPhoto of Jesse Cedarbaum

Jesse Cedarbaum

Chief Medical Officer

Board

BDPhoto of Bernard Davitian

Bernard Davitian

Board Member

MAPhoto of Mona Ashiya

Mona Ashiya

Board Member

SNPhoto of Sara Nayeem

Sara Nayeem

Board Member

DKPhoto of Dimitri Krainc

Dimitri Krainc

Scientific Advisor

JSPhoto of James B. Summers

James B. Summers

Scientific Advisor

GGPhoto of Gregory Grabowski

Gregory Grabowski

Scientific Advisor